Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Can we override clopidogrel resistance?

× No keyword cloud information.

14 in total

1. Publishing genomic studies: walking the fine line.

Authors: Arthur M Feldman
Journal: Clin Transl Sci Date: 2012-02 Impact factor: 4.689

Review 2. Personalized approaches to clopidogrel therapy: are we there yet?

Authors: Christopher D Anderson; Alessandro Biffi; Steven M Greenberg; Jonathan Rosand
Journal: Stroke Date: 2010-10-28 Impact factor: 7.914

3. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

Authors: Jessica L Mega; Tabassome Simon; Jean-Philippe Collet; Jeffrey L Anderson; Elliott M Antman; Kevin Bliden; Christopher P Cannon; Nicolas Danchin; Betti Giusti; Paul Gurbel; Benjamin D Horne; Jean-Sebastian Hulot; Adnan Kastrati; Gilles Montalescot; Franz-Josef Neumann; Lei Shen; Dirk Sibbing; P Gabriel Steg; Dietmar Trenk; Stephen D Wiviott; Marc S Sabatine
Journal: JAMA Date: 2010-10-27 Impact factor: 56.272

4. Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.

Authors: Ehud Regev; Elad Asher; Paul Fefer; Roy Beigel; Israel Mazin; Shlomi Matetzky
Journal: PLoS One Date: 2018-04-06 Impact factor: 3.240

Review 5. [Antiplatelet therapy after acute coronary syndrome. Therapeutic strategies and treatment duration].

Authors: C B Olivier; P Diehl; C Bode; M Moser
Journal: Herz Date: 2014-11 Impact factor: 1.443

Review 6. Antiplatelet agents in hemodialysis.

Authors: Massimiliano Migliori; Vincenzo Cantaluppi; Alessia Scatena; Vincenzo Panichi
Journal: J Nephrol Date: 2016-12-08 Impact factor: 3.902

7. Responding to the clopidogrel warning by the US food and drug administration: real life is complicated.

Authors: Dan M Roden; Alan R Shuldiner
Journal: Circulation Date: 2010-06-28 Impact factor: 29.690

Review 8. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy.

Authors: S A Scott; K Sangkuhl; E E Gardner; C M Stein; J-S Hulot; J A Johnson; D M Roden; T E Klein; A R Shuldiner
Journal: Clin Pharmacol Ther Date: 2011-06-29 Impact factor: 6.875

9. Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.

Authors: Richard B Horenstein; Rajnikanth Madabushi; Issam Zineh; Laura M Yerges-Armstrong; Cody J Peer; Robert N Schuck; William Douglas Figg; Alan R Shuldiner; Michael A Pacanowski
Journal: J Clin Pharmacol Date: 2014-04-07 Impact factor: 3.126

Review 10. Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.

Authors: Marlene S Williams; Ethan J Weiss; Marc S Sabatine; Daniel I Simon; Wadie F Bahou; Lewis C Becker; Leslie V Parise; Harold L Dauerman; Patricia A French; Susan S Smyth; Richard C Becker
Journal: Arterioscler Thromb Vasc Biol Date: 2010-12 Impact factor: 8.311